UPDATE Throne Biotechnologies Private
4 years ago - BUSSINESS - New York City - 17 viewsFind a cure type 1 diabetes, alopecia areata, and other autoimmune disease...
((( Throne Biotechnologies)))
3/29/2022
$145K+ ((($145,343+)))
71+ Investors // 2New
$7.59 Share
$349.14/Min Investments
$120M VALUATION!!!!!
$1.01M Offering Max!!!
@Yong Zhao, MD, PhD
@Theodore Mazzone, MD
@John R Hume
https://www.linkedin.com/in/john-hme-0268556a/
@Manosh k Sinha
www.linkedin.com/in/manoshksinha48/
https://www.startengine.com/throne-biotechnologies
Throne offers the Practical Cure for type 1 diabetes, alopecia areata, and other autoimmune diseases through its patented technology, Stem Cell Educator therapy — a one-time, dialysis-like treatment that fundamentally “re-educates” the defective immune system back to health. Throne is in the pre-revenue clinical stage of development.
STILL ACCEPTING.